Type 1 diabetes according to ADA criterias <5 years.
Age= 18 years and less than 70 years.
Non-obese: defined as BMI less than 28 kg/m2
Positive for at least one of the anti-islet autoantibodies: GADA, IA2A, ZnT8A
Fasting or postprandial plasma C-peptide more than 100 pmol/L
Written informed consent from the patient or family representative.

NCT03513874_inc_T1
Condition
Type 1 diabetes
NCT03513874_inc_T2
Qualifier
ADA criterias
NCT03513874_inc_T3
Temporal
<5 years
NCT03513874_inc_T4
Person
Age
NCT03513874_inc_T5
Value
= 18 years and less than 70 years
NCT03513874_inc_T6
Negation
Non
NCT03513874_inc_T7
Condition
obese
NCT03513874_inc_T8
Measurement
BMI
NCT03513874_inc_T9
Value
less than 28 kg/m2
NCT03513874_inc_T10
Multiplier
at least one
NCT03513874_inc_T11
Condition
anti-islet autoantibodies
NCT03513874_inc_T12
Condition
GADA
NCT03513874_inc_T13
Condition
IA2A
NCT03513874_inc_T14
Condition
ZnT8A
NCT03513874_inc_T15
Scope
GADA, IA2A, ZnT8A
NCT03513874_inc_T16
Measurement
postprandial plasma C-peptide
NCT03513874_inc_T17
Measurement
ing or ma C-peptide mor
NCT03513874_inc_T18
Scope
Fasting or postprandial plasma C-peptide
NCT03513874_inc_T19
Value
more than 100 pmol/L